Skip to Main Content

Try STAT+ TODAY

legal

Most Read

Purdue Pharmaceuticals

Pharmalot By Ed Silverman

Sacklers agree to $6 billion Purdue bankruptcy settlement over opioid crisis

crushed pill/red background

First Opinion By Mark Reisenauer

Inappropriate march-in actions would jeopardize public-private partnerships that make lifesaving medicines possible

FertilityThermostatLawsuit_Illustration_MollyFerguson_022822

Health Tech By Kate Sheridan and Casey Ross

In a defamation lawsuit, the hype around digital health clashes with scientific criticism

Biotech By Megan Molteni

3 burning questions spurred by the big CRISPR patent ruling

Supreme Court opioid prescribing

Health By Andrew Joseph

Supreme Court debates exactly when a doctor’s misprescribing becomes criminal

gavel pill patent

Pharmalot By Ed Silverman

Tennessee judge sanctions Endo for withholding opioid documents, refuses to recuse himself from case

Jennifer Doudna

Biotech By Megan Molteni

UC Berkeley loses CRISPR patent case, invalidating patent rights it granted gene-editing companies developing human therapies

Johnson & Johnson sign

Pharmalot By Ed Silverman

Johnson & Johnson, three pharma wholesalers finalize $26 billion opioid crisis settlement

All Coverage

Health By Olivia Goldhill

Vague ‘medical emergency’ exceptions in abortion laws leave pregnant people in danger, doctors say

gavel pill patent

Pharmalot By Ed Silverman

Drugmakers win court battle over an HHS rule that would have penalized them for offering copay coupons

advertisement

Health By Olivia Goldhill

Psychedelic medicine group investigating a board member accused of financial elder abuse

Bribery

Pharmalot By Ed Silverman

Greece plans to go to court to seek compensation from Novartis over a bribery scandal

Hospitals By Tara Bannow

Advocate Aurora-Atrium’s mammoth merger: Experts split on whether federal regulators will challenge the deal

Drug pricing transparency

Pharmalot By Ed Silverman

J&J sues a behind-the-scenes company for exploiting its patient assistance program

Pharmalot By Ed Silverman

Pharmalittle: Investors reject proposals for Covid vaccine makers to share know-how; CMS head says Alzheimer’s drug decision is rare

Out of network

Business By Bob Herman

The doctor who is trying to bring back surprise billing

Insurance By Tara Bannow

Federal antitrust case against Sutter Health headed for appeal

Shopping cart illo

Pharmalot By Ed Silverman

Usual and customary? Rite Aid ordered to pay Humana $123 million for inflating pharmacy claims

travel mask mandate

First Opinion By Jeffrey E. Harris

In mask mandate case, judge ruled on wordplay, not public health

Psychedelic crime illustration

A STAT Investigation By Olivia Goldhill

A psychedelic therapist allegedly took millions from a Holocaust survivor, highlighting worries about elders taking hallucinogens

gavel pill patent

Pharmalot By Ed Silverman

Endo wins a reprieve in an opioid lawsuit in Tennessee as appeals court overturns sanctions

UnitedHealth Group

Pharmalot By Ed Silverman

Louisiana accuses UnitedHealth and its OptumRx PBM of inflating drug costs for its Medicaid program

Bristol Myers Squibb sign

Pharmalot By Ed Silverman

Bristol Myers agrees to settle lawsuit alleging anti-competitive deals involving HIV drugs

D.C. Insight IMAGE

D.C. Diagnosis By Nicholas Florko

The next battle in the never-ending war over Aduhelm

Gavel and Stethoscope due process

Politics By Nicholas Florko

Will Biogen sue Medicare over its restrictions on the Alzheimer’s drug, Aduhelm? And other big legal questions about the decision

Pharmalot By Ed Silverman

Pharma companies face shareholder proposals to widen access to medicines, rework business practices

Drug Pricing

Pharmalot By Ed Silverman

HHS seeks to penalize another drugmaker amid legal clash over drug discount program

private equity health care

First Opinion By Jeanne A. Markey and Raymond M. Sarola

Private equity, health care, and profits: It’s time to protect patients

Opioid photo illustration opioid overdose

Pharmalot By Ed Silverman

Teva and Allergan reach $107 million deal with Rhode Island over opioid crisis

Painkillers

Pharmalot By Ed Silverman

Dozens of towns and counties object to ‘hush money’ tied to Purdue opioid settlement

Mallinckrodt Pharmaceuticals

Pharmalot By Ed Silverman

Mallinckrodt to pay $260 million to settle federal lawsuits over Medicaid rebates and kickbacks

Patent folder

First Opinion By Adam Mossoff

The U.S. must fix its innovation engine: the patent system

state medical licensing

First Opinion By Bret Mettler

Sunsetting medical license reciprocity would return medicine to the dark ages